Objectives:
* To compare local progression-free survival following palliation with SBRT versus traditional fractionations in patients with HN SCC deemed ineligible for curative-intent treatment.
* To compare pain response, symptom burden, toxicity, local control, progression-free survival, and overall survival between the treatment modalities.